Tuesday Dec 8, 2015
Two more medicines will be funded by taxpayers for the treatment of multiple sclerosis, following a decision by Government agency Pharmac.
Tecfidera capsules and Aubagio tablets will be state-funded from February 1 for MS patients who meet the complex clinical criteria.
The Multiple Sclerosis Society of New Zealand welcomes the decision to fund two new first-line treatments for relapsing-remitting forms of MS.
“There are approximately 4000 people with multiple sclerosis in New Zealand,” says society spokesman Neil Woodhams. “This announcement is a really positive step forward for them.”
The announcement follows Pharmac’s funding of two other MS medicines, Tysabri and Gilenya, last year and its widening of access to older injectable treatments.
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
MS Views and News helps to provide information for all affected by MS
Keep up to date with the news and information we provide
by signing up by clicking here
.===================================
Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews